Sage Journals: Discover world-class research

Abstract

OBJECTIVE: We sought to compare the overall 1-year management costs for patients receiving a free tissue transfer with those of patients receiving a pedicled flap reconstruction as a component of their primary head and neck cancer treatment.

STUDY DESIGN AND SETTING: Case-control, cost identification analysis of 21 matched pairs of patients and multivariate analysis of variables associated with treatment costs was conducted in a tertiary referral academic institution.

RESULTS: No significant difference in total 1-year charges between the pedicled and free tissue transfer groups was found. A structured measure of patient comorbidity was the only variable significantly associated with total 1-year charges.

CONCLUSIONS: Total 1-year treatment costs of primary upper aerodigestive tract cancers are similar for patients reconstructed with free tissue transfer or a pedicled flap.

SIGNIFICANCE: Within the context of overall 1-year management costs, the primary determinants of health care expense for these patients are comorbidity and extent of disease, not reconstructive technique.

Get full access to this article

View all access options for this article.

References

Schulman

Glick

Yabroff

Introduction to clinical economics: Assessment of cancer therapies. J Natl Cancer Inst Monographs 1995; 19:1–9.

Smith

Hillner

Desch

CE.

Efficacy and cost-effectiveness of cancer treatment: Rational allocation of resources based on decision analysis. J Natl Cancer Inst 1993; 85:1460–74.

Thoma

Veltri

Archibald

Microsurgical reconstruction of the through-and-through defect in head and neck cancer: Is it worth it?

J Reconstr Microsurg 1999; 15:401–8.

Funk

Hoffman

Karnell

Cost-identification analysis in oral cavity cancer management. Otolaryngol Head Neck Surg 1998; 118:211–20.

Arnold

Funk

Karnell

Laryngeal cancer cost analysis: Association of case-mix and treatment characteristics with medical charges. Laryngoscope 2000; 110:1–7.

Urken

Buchbinder

Weinberg

Functional evaluation after microvascular oromandibular reconstruction of the oral cancer patient: A comparative study of reconstructed and nonreconstructed patients. Laryngoscope 1991; 101:935–50.

Tsue

Desyatnikova

Deleyiannis

FW-B

Comparison of cost and function in reconstruction of the posterior oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 1997; 123:731–7.

Talesnik

Markowitz

Calcaterra

Cost and outcome of osteocutaneous free-tissue transfer versus pedicled soft-tissue reconstruction for composite mandibular defects. Plast Reconstr Surg 1996; 97:1167–78.

Kroll

Schusterman

Reece

GP.

Costs and complications in mandibular reconstruction. Ann Plastic Surg 1992; 29:341–7.

10.

Kroll

Evans

GRD

Goldberg

A comparison of resource costs for head and neck reconstruction with free and pectoralis major flaps. Plast Reconstr Surg 1997; 99:1282–6.

11.

Miller

Swartz

Miller

Cost analysis of microsurgical reconstruction in the head and neck. J Surg Oncol 1991; 46:230–4.

12.

Cohen

Stock

Andersen

Critical pathways for head and neck surgery: Development and implementation. Arch Otolaryngol Head Neck Surg 1997; 123:11–14.

13.

Cohen

Stock

Chan

Microvascular reconstruction and tracheotomy are significant determinants of resource utilization in head and neck surgery. Arch Otolaryngol Head Neck Surg 2000; 126:947–9.

14.

Smeele

Irish

Gullane

A retrospective comparison of the morbidity and cost of different reconstructive strategies in oral and oropharyngeal carcinoma. Laryngoscope 1999; 109:800–4.

15.

Funk

Arnold

DJ.

Cost analysis in head and neck oncology. Curr Opin Otolaryngol Head Neck Surg 1998; 6:106–12.

16.

Brown

McCulloch

Funk

Resource utilization and patient morbidity in head and neck reconstruction. Laryngoscope 1997; 107:1028–31.

17.

Hall

Mooney

What every doctor should know about economics, part 2: The benefits of economic appraisal. Med J Austral 1990; 152:80–2.

18.

Citybank Economic Database New York: New York Bank, North America, 1978.

19.

SAS Institute Inc SAS/STAT User's Guide, Version 6, 4th edition. Cary, NC: SAS Institute Inc, 1989.

20.

Kaplan

Feinstein

AR.

The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974; 27:387–404.

21.

Vitez

TS.

Principles of cost analysis. J Clin Anesth 1994; 6:357–63.

22.

Eisenberg

JM.

Clinical economics: A guide to the economic analysis of clinical practices. JAMA 1989; 262:2879–86.

23.

Weinstein

MC.

Tutorial: Economic assessments of medical practices and technologies. Med Decis Making 1981; 1:309–30.

24.

Brown

ML.

The national economic burden of cancer: An update. J Natl Cancer Inst 1990; 82:1811–4.

25.

U.S. Public Health Service Cost-Effectiveness in Health and Medicine. Maryland: U.S. Government Printing Office; 1996.

26.

Weinstein

Stason

WB.

Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296:716–21.

Free Tissue Transfer versus Pedicled Flap Cost in Head and Neck Cancer

Abstract

Get full access to this article

References